Document Detail

The vasoactive intestinal peptide gene is a key modulator of pulmonary vascular remodeling and inflammation.
MedLine Citation:
PMID:  19076374     Owner:  NLM     Status:  MEDLINE    
Pulmonary vascular remodeling and inflammation often coexist in clinical and experimentally induced pulmonary arterial hypertension (PAH). In some instances, the pulmonary hypertension may be the primary, or at least the initial, problem, while inflammatory or autoimmune responses appear to initiate or dominate the picture in other cases. Based on studies in a model of PAH resulting from targeted deletion of the neuropeptide vasoactive intestinal peptide (VIP) gene, we propose that, at least in this experimental model, but possibly also in other situations, both vascular remodeling and inflammation may be mediated by one and the same mechanism: uncontrolled activation of calcineurin-NFAT (nuclear factor of activated T cells) signaling. If this hypothesis is validated, VIP would emerge as an endogenous modulator of pulmonary vascular remodeling and inflammation, through its suppression of NFAT activation.
Sami I Said
Related Documents :
6398164 - Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and ...
6746084 - Connective tissue accumulation in the left coronary artery of young shr.
10214474 - Primary pulmonary hypertension with fatal outcome in a young woman and review of the li...
16378894 - A rare cause of fatal right heart failure.
2802864 - Truncus arteriosus with interrupted aortic arch: successful correction in a neonate.
9768994 - Minimally invasive coronary artery bypass grafting without cardiopulmonary bypass: earl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1144     ISSN:  1749-6632     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-12-16     Completed Date:  2009-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  148-53     Citation Subset:  IM    
Pulmonary and Critical Care Medicine, SUNY Health Sciences Center, Stony Brook, NY 11794-8172, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hypertension, Pulmonary / immunology*,  metabolism,  pathology
Lung / blood supply*,  metabolism*
Models, Animal
Models, Biological
NFATC Transcription Factors / metabolism
Pneumonia / metabolism*
Pulmonary Artery / metabolism,  pathology
Vasoactive Intestinal Peptide / genetics,  physiology*
Reg. No./Substance:
0/NFATC Transcription Factors; 37221-79-7/Vasoactive Intestinal Peptide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gastrin-releasing peptide, immune responses, and lung disease.
Next Document:  Prenatal alcohol exposure increases vulnerability to stress and anxiety-like disorders in adulthood.